Teladoc Health Inc (TDOC) concluded trading on Wednesday at a closing price of $8.64, with 3.87 million shares of worth about $33.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.35% during that period and on March 26, 2025 the price saw no change. Currently the company’s common shares owned by public are about 173.41M shares, out of which, 171.93M shares are available for trading.
Stock saw a price change of 1.77% in past 5 days and over the past one month there was a price change of -22.72%. Year-to-date (YTD), TDOC shares are showing a performance of -4.95% which decreased to -42.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.76 but also hit the highest price of $15.43 during that period. The average intraday trading volume for Teladoc Health Inc shares is 7.59 million. The stock is currently trading -2.71% below its 20-day simple moving average (SMA20), while that difference is down -15.96% for SMA50 and it goes to -8.16% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 173.41M outstanding shares and institutions hold larger chunk of about 73.78% of that.
The stock has a current market capitalization of $1.50B and its 3Y-monthly beta is at 1.73. It has posted earnings per share of -$5.88 in the same period. It has Quick Ratio of 1.69 while making debt-to-equity ratio of 1.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 4.54% while standing at 5.92% over the month.
Stock’s fiscal year EPS is expected to rise by 83.83% while it is estimated to increase by 9.26% in next year. EPS is likely to grow at an annualized rate of 48.98% for next 5-years, compared to annual growth of -33.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
